Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1985;63(2):317–323.

Serotypes of Plasmodium falciparum defined by immune serum inhibition of in vitro growth*

J D Chulay, J D Haynes, C L Diggs
PMCID: PMC2536403  PMID: 3893775

Abstract

In vitro growth inhibition assays were used to detect antigenic differences among geographically distinct strains of Plasmodium falciparum. Owl monkeys were immunized against the Camp and FCR-3/FMG strains of P. falciparum by infection, drug treatment, and rechallenge with homologous parasites. Camp-immune monkey serum was used to inhibit the in vitro growth of eight strains of P. falciparum. Inhibition was maximum for the homologous Camp strain (an average of 62% inhibition by 100 ml/litre Camp-immune serum). Four other strains were inhibited to a lesser degree, and three strains (FCR-3/FMG, FVO, and Smith) were not significantly inhibited by Camp-immune serum at concentrations as high as 400 ml/litre. FCR-3/FMG-immune serum at a concentration of 50 ml/litre caused significant inhibition of the FCR-3/FMG strain, but not the Camp strain. Thus Camp and FCR-3/FMG strains appear to bear distinct antigenic determinants recognized by the homologous, but not the heterologous, antiserum. Inhibition of in vitro growth by immune serum may be useful for serotyping P. falciparum and may have application in the selection of strains for inclusion in a malaria vaccine.

Full text

PDF
317

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BODIAN D. Second attacks of paralytic poliomyelitis in human beings in relation to immunity, virus types and virulence, with a report of two cases, and four other individuals in Baltimore, 1944, infected with virus of the Leon type. Am J Hyg. 1951 Sep;54(2):174–190. doi: 10.1093/oxfordjournals.aje.a119475. [DOI] [PubMed] [Google Scholar]
  2. BRAY R. S., GUNDERS A. E., BURGESS R. W., FREEMAN J. B., ETZEL E., GUTTUSO C., COLUSSA B. The inoculation of semi-immune Africans with sporozoites of Laverania falcipara (Plasmodium falciparum) in Liberia. Riv Malariol. 1962 Dec;41:199–210. [PubMed] [Google Scholar]
  3. Brown K. N., Brown I. N. Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi. Nature. 1965 Dec 25;208(5017):1286–1288. doi: 10.1038/2081286a0. [DOI] [PubMed] [Google Scholar]
  4. Canfield C. J., Whiting E. G., Hall W. H., MacDonald B. S. Treatment of acute falciparum malaria from Vietnam with trimethoprim and sulfalene. Am J Trop Med Hyg. 1971 Jul;20(4):524–526. doi: 10.4269/ajtmh.1971.20.524. [DOI] [PubMed] [Google Scholar]
  5. Carter R., Beach R. F. Gametogenesis in culture by gametocytes of Plasmodium falciparum. Nature. 1977 Nov 17;270(5634):240–241. doi: 10.1038/270240a0. [DOI] [PubMed] [Google Scholar]
  6. Chulay J. D., Aikawa M., Diggs C., Haynes J. D. Inhibitory effects of immune monkey serum on synchronized Plasmodium falciparum cultures. Am J Trop Med Hyg. 1981 Jan;30(1):12–19. doi: 10.4269/ajtmh.1981.30.12. [DOI] [PubMed] [Google Scholar]
  7. Chulay J. D., Haynes J. D., Diggs C. L. Inhibition of in vitro growth of Plasmodium falciparum by immune serum from monkeys. J Infect Dis. 1981 Sep;144(3):270–278. doi: 10.1093/infdis/144.3.270. [DOI] [PubMed] [Google Scholar]
  8. Desjardins R. E., Canfield C. J., Haynes J. D., Chulay J. D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979 Dec;16(6):710–718. doi: 10.1128/aac.16.6.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. FELSENFELD O. BORRELIAE, HUMAN RELAPSING FEVER, AND PARASITE-VECTOR-HOST RELATIONSHIPS. Bacteriol Rev. 1965 Mar;29:46–74. doi: 10.1128/br.29.1.46-74.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Green T. J., Morhardt M., Brackett R. G., Jacobs R. L. Serum inhibition of merozoite dispersal from Plasmodium falciparum schizonts: indicator of immune status. Infect Immun. 1981 Mar;31(3):1203–1208. doi: 10.1128/iai.31.3.1203-1208.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hickman R. L. The use of subhuman primates for experimental studies of human malaria. Mil Med. 1969 Sep;134(10):741–756. [PubMed] [Google Scholar]
  12. James S. P., Nicol W. D., Shute P. G. A Study of Induced Malignant Tertian Malaria. Proc R Soc Med. 1932 Jun;25(8):1153–1186. [PMC free article] [PubMed] [Google Scholar]
  13. Jensen J. B., Capps T. C., Carlin J. M. Clinical drug-resistant falciparum malaria acquired from cultured parasites. Am J Trop Med Hyg. 1981 May;30(3):523–525. doi: 10.4269/ajtmh.1981.30.523. [DOI] [PubMed] [Google Scholar]
  14. Jensen J. B., Trager W. Plasmodium falciparum in culture: establishment of additional strains. Am J Trop Med Hyg. 1978 Jul;27(4):743–746. doi: 10.4269/ajtmh.1978.27.743. [DOI] [PubMed] [Google Scholar]
  15. Langreth S. G., Reese R. T. Antigenicity of the infected-erythrocyte and merozoite surfaces in Falciparum malaria. J Exp Med. 1979 Nov 1;150(5):1241–1254. doi: 10.1084/jem.150.5.1241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McBride J. S., Walliker D., Morgan G. Antigenic diversity in the human malaria parasite Plasmodium falciparum. Science. 1982 Jul 16;217(4556):254–257. doi: 10.1126/science.6178159. [DOI] [PubMed] [Google Scholar]
  17. Nguyen-Dinh P., Trager W. Chloroquine resistance produced in vitro in an African strain of human malaria. Science. 1978 Jun 23;200(4348):1397–1398. doi: 10.1126/science.351801. [DOI] [PubMed] [Google Scholar]
  18. Sadun E. H., Hickman R. L., Wellde B. T., Moon A. P., Udeozo I. O. Active and passive immunization of chimpanzees infected with West African and Southeast Asian strains of Plasmodium falciparum. Mil Med. 1966 Sep;131(9 Suppl):1250–1262. [PubMed] [Google Scholar]
  19. Sanderson A., Walliker D., Molez J. F. Enzyme typing of Plasmodium falciparum from African and some other Old World countries. Trans R Soc Trop Med Hyg. 1981;75(2):263–267. doi: 10.1016/0035-9203(81)90331-x. [DOI] [PubMed] [Google Scholar]
  20. Schmidt L. H., Crosby R., Rasco J., Vaughan D. Antimalarial activities of the 4-quinolinemethanols WR-184,806 and WR-226,253. Antimicrob Agents Chemother. 1978 Nov;14(5):680–689. doi: 10.1128/aac.14.5.680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Siddiqui W. A., Schnell J. V., Geiman Q. M. A model in vitro system to test the susceptibility of human malarial parasites to antimalarial drugs. Am J Trop Med Hyg. 1972 Jul;21(4):393–399. [PubMed] [Google Scholar]
  22. Siddiqui W. A., Taylor D. W., Kan S. C., Kramer K., Richmond-Crum S. Partial protection of Plasmodium falciparum-vaccinated Aotus trivirgatus against a challenge of a heterologous strain. Am J Trop Med Hyg. 1978 Nov;27(6):1277–1278. doi: 10.4269/ajtmh.1978.27.1277. [DOI] [PubMed] [Google Scholar]
  23. Tait A. Analysis of protein variation in Plasmodium falciparum by two-dimensional gel electrophoresis. Mol Biochem Parasitol. 1981 Feb;2(3-4):205–218. doi: 10.1016/0166-6851(81)90101-8. [DOI] [PubMed] [Google Scholar]
  24. Vernes A., Haynes J. D., Tapchaisri P., Williams J. L., Dutoit E., Diggs C. L. Plasmodium falciparum strain-specific human antibody inhibits merozoite invasion of erythrocytes. Am J Trop Med Hyg. 1984 Mar;33(2):197–203. doi: 10.4269/ajtmh.1984.33.197. [DOI] [PubMed] [Google Scholar]
  25. Vickerman K. Antigenic variation in trypanosomes. Nature. 1978 Jun 22;273(5664):613–617. doi: 10.1038/273613a0. [DOI] [PubMed] [Google Scholar]
  26. Voller A., Richards W. H. Immunity to Plasmodium falciparum in owl monkeys (Aotus trivirgatus). Z Tropenmed Parasitol. 1970 Jun;21(2):159–166. [PubMed] [Google Scholar]
  27. Wilson R. J., Phillips R. S. Method to test inhibitory antibodies in human sera to wild populations of Plasmodium falciparum. Nature. 1976 Sep 9;263(5573):132–134. doi: 10.1038/263132a0. [DOI] [PubMed] [Google Scholar]
  28. Wilson R. J. Serotyping Plasmodium falciparum malaria with S-antigens. Nature. 1980 Apr 3;284(5755):451–452. doi: 10.1038/284451a0. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES